Logo image of PBM

PSYENCE BIOMEDICAL LTD (PBM) Stock Price, Quote, News and Overview

NASDAQ:PBM - Nasdaq - CA74449F1009 - Common Stock - Currency: USD

1.03  -0.21 (-16.94%)

Premarket: 0.9513 -0.08 (-7.64%)

PBM Quote, Performance and Key Statistics

PSYENCE BIOMEDICAL LTD

NASDAQ:PBM (3/3/2025, 8:00:02 PM)

Premarket: 0.9513 -0.08 (-7.64%)

1.03

-0.21 (-16.94%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High165
52 Week Low1
Market Cap4.03M
Shares3.91M
Float3.81M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO12-10 2021-12-10


PBM short term performance overview.The bars show the price performance of PBM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

PBM long term performance overview.The bars show the price performance of PBM in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of PBM is 1.03 USD. In the past month the price decreased by -34.39%. In the past year, price decreased by -99.35%.

PSYENCE BIOMEDICAL LTD / PBM Daily stock chart

PBM Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 20.9 373.71B
AMGN AMGEN INC 15.68 166.89B
GILD GILEAD SCIENCES INC 25.16 144.52B
VRTX VERTEX PHARMACEUTICALS INC 1666.59 124.16B
REGN REGENERON PHARMACEUTICALS 15.01 74.87B
ARGX ARGENX SE - ADR 242.26 37.83B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 31.41B
BNTX BIONTECH SE-ADR N/A 26.75B
ONC BEIGENE LTD-ADR N/A 26.20B
BIIB BIOGEN INC 8.6 20.65B
NTRA NATERA INC N/A 18.89B
GMAB GENMAB A/S -SP ADR 24.69 14.59B

About PBM

Company Profile

PBM logo image Psyence Biomedical Ltd. is a life science biotechnology company. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-12-10. The firm has partnered with iNGENu Pty Ltd (iNGENu) to conduct the Company’s clinical trial in palliative care. iNGENu is an Australia-based, globally focused contract research organization (CRO) with experience working in the psychedelic pharmaceutical drug development and clinical research industry. Its Phase IIb clinical trial, using PEX010, a 25mg naturally derived psilocybin drug candidate product in-licensed by the Company, in the palliative care setting.

Company Info

PSYENCE BIOMEDICAL LTD

121 Richmond Street West Penthouse, Suite 1300

TORONTO ONTARIO V6E 3Z3 CA

CEO: John Plourde

Employees: 0

Company Website: http://psyence.com

Investor Relations: http://psyence.com/investors/

Phone: 17744604171

PSYENCE BIOMEDICAL LTD / PBM FAQ

What is the stock price of PSYENCE BIOMEDICAL LTD today?

The current stock price of PBM is 1.03 USD. The price decreased by -16.94% in the last trading session.


What is the ticker symbol for PSYENCE BIOMEDICAL LTD stock?

The exchange symbol of PSYENCE BIOMEDICAL LTD is PBM and it is listed on the Nasdaq exchange.


On which exchange is PBM stock listed?

PBM stock is listed on the Nasdaq exchange.


What is PSYENCE BIOMEDICAL LTD worth?

PSYENCE BIOMEDICAL LTD (PBM) has a market capitalization of 4.03M USD. This makes PBM a Nano Cap stock.


How many employees does PSYENCE BIOMEDICAL LTD have?

PSYENCE BIOMEDICAL LTD (PBM) currently has 0 employees.


Should I buy PSYENCE BIOMEDICAL LTD (PBM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PSYENCE BIOMEDICAL LTD (PBM) stock pay dividends?

PBM does not pay a dividend.


What is the Short Interest ratio of PSYENCE BIOMEDICAL LTD (PBM) stock?

The outstanding short interest for PSYENCE BIOMEDICAL LTD (PBM) is 7.71% of its float. Check the ownership tab for more information on the PBM short interest.


PBM Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

PBM Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

PBM Ownership and Analysts


Ownership
Inst Owners21.57%
Ins OwnersN/A
Short Float %7.71%
Short Ratio0.12
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A